- Home
- WFC vs ABT Comparison
WFC vs ABT Comparison
Compare WFC & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WFC
- ABT
- Stock Information
- Founded
- WFC 1852
- ABT 1888
- Country
- WFC United States
- ABT United States
- Employees
- WFC N/A
- ABT N/A
- Industry
- WFC Major Banks
- ABT Medical/Dental Instruments
- Sector
- WFC Finance
- ABT Health Care
- Exchange
- WFC Nasdaq
- ABT Nasdaq
- Market Cap
- WFC 235.8B
- ABT 204.9B
- IPO Year
- WFC N/A
- ABT N/A
- Fundamental
- Price
- WFC $70.36
- ABT $114.21
- Analyst Decision
- WFC Buy
- ABT Buy
- Analyst Count
- WFC 22
- ABT 15
- Target Price
- WFC $67.82
- ABT $129.80
- AVG Volume (30 Days)
- WFC 18.5M
- ABT 5.2M
- Earning Date
- WFC 01-15-2025
- ABT 01-22-2025
- Dividend Yield
- WFC 2.27%
- ABT 1.93%
- EPS Growth
- WFC 1.87
- ABT 12.04
- EPS
- WFC 4.79
- ABT 3.29
- Revenue
- WFC $77,875,000,000.00
- ABT $41,217,000,000.00
- Revenue This Year
- WFC N/A
- ABT $5.73
- Revenue Next Year
- WFC $0.50
- ABT $7.17
- P/E Ratio
- WFC $14.69
- ABT $34.72
- Revenue Growth
- WFC 1.03
- ABT 3.15
- 52 Week Low
- WFC $46.12
- ABT $99.71
- 52 Week High
- WFC $78.13
- ABT $121.64
- Technical
- Relative Strength Index (RSI)
- WFC 46.28
- ABT 46.60
- Support Level
- WFC $68.61
- ABT $111.28
- Resistance Level
- WFC $72.29
- ABT $114.15
- Average True Range (ATR)
- WFC 1.73
- ABT 1.77
- MACD
- WFC -0.79
- ABT -0.28
- Stochastic Oscillator
- WFC 24.10
- ABT 47.56
About WFC Wells Fargo & Company
Wells Fargo is one of the largest banks in the United States, with approximately $1.9 trillion in balance sheet assets. The company has four primary segments: consumer banking, commercial banking, corporate and investment banking, and wealth and investment management. It is almost entirely focused on the U.S.
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.